← back to search

Richard Parslew

Royal Liverpool University Hospital · GB
Area of research
Immunology · Dermatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, and Cutaneous Melanoma Detection and Management.
h-index
23
citations
2,313
works
93
NIH funding
primary concept
email

Recent publications

A genome-wide meta-analysis of palmoplantar pustulosis implicates TH2 responses and cigarette smoking in disease pathogenesis
Journal of Allergy and Clinical Immunology 2024cited by 19position: middledoi
Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis
Journal of Allergy and Clinical Immunology 2022cited by 72position: middledoi
Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)*
British Journal of Dermatology 2021cited by 33position: middledoi
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update
British Journal of Dermatology 2020cited by 222position: middledoi
Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease
The American Journal of Human Genetics 2020cited by 68position: middledoi
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis
JAMA Dermatology 2020cited by 41position: middledoi
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis
Journal of Investigative Dermatology 2017cited by 141position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

A. David Burden · University of Edinburgh3 papers (2017–2022)Catherine Smith · City College of San Francisco3 papers (2017–2022) · 2 papers (2017–2020)Zenas Z N Yiu · University of Manchester2 papers (2017–2020) · 2 papers (2017–2020)Caroline Owen · Royal Blackburn Teaching Hospital2 papers (2017–2020)Ruth Murphy · University of Manchester2 papers (2017–2020)Richard B. Warren · Novartis (Switzerland)2 papers (2017–2022)Andrew Pink · King's College London1 papers (2022–2022)Natashia Benzian-Olsson · King's College London1 papers (2022–2022) · 1 papers (2017–2017) · 1 papers (2020–2020)N. J. Levell · University of Dundee1 papers (2022–2022)Nick J. Reynolds · University of Newcastle Australia1 papers (2022–2022)Daniel McCluskey · King's College London1 papers (2022–2022) · 1 papers (2017–2017)John R Ingram · Institute of Infection and Immunity1 papers (2022–2022)Zarif K. Jabbar‐Lopez · Galderma (Switzerland)1 papers (2017–2017) · 1 papers (2022–2022)Richard Woolf · St Thomas' Hospital1 papers (2020–2020)